Want to join the conversation?
Barclays analyst Raimo Lenschow questions on the Enterprise Security business drivers for 2017. $SYMC CFO Thomas Seifert says that the company is dealing with dangers in how new products are sold and how buying preferences are changing. The company has tried to anticipate this with the guidance for FY17.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?